EvE Bio Releases Comprehensive Dataset Mapping FDA-Approved Drugs to Cellular Receptors
By
abhishaike
Pure flour-power. Hearty enough to carry you through lunch.
Summary
EvE Bio has created a comprehensive dataset mapping interactions between approximately 1,600 FDA-approved drugs and clinically important human cellular receptors, revealing off-target effects of existing medications. The dataset, released under a CC-NA license, represents a significant resource for drug discovery and safety research by systematically identifying unintended drug interactions that could lead to new therapeutic applications or safety concerns.
Key quotes
· 4 pulledThis dataset, which was produced by EvE Bio underneath a CC-NA license, and is a comprehensive mapping of the interactions between a significant fraction of clinically important human cellular receptors and 1,600~ FDA-approved drugs.
I strongly believe that this data is really, really useful, and more people should be aware it exists.
The real headline point you need to be aware of is this dataset, which was produced by EvE Bio underneath a CC-NA license.
Mapping the off-target effects of every FDA-approved drug in existence.
You might also wanna read
Experimental pill daraxonrasib extends survival in advanced pancreatic cancer patients, study finds
Researchers reported that daraxonrasib, a novel experimental pill, helped patients with advanced pancreatic cancer live longer by blocking a
npr.org·8h ago
GeneSkin Develops mRNA Therapy Targeting Skin Stem Cells for Rejuvenation and Hair Growth
GeneSkin is developing a novel mRNA therapy targeting basal stem cells in the skin to address a wide range of dermatological issues includin
wyss.harvard.edu·11h ago
First human trial begins for drug that could regrow missing teeth
Kyoto University Hospital has launched the first human trial of TRG-035, a drug designed to regrow teeth in adults by blocking a protein tha
boingboing.net·1d ago
Japanese researchers develop vitamin K-like compounds that may help convert brain cells into neurons
Japanese researchers have developed a new family of vitamin K-like molecules that may help immature brain cells transition into neurons. Whi
zmescience.com·1d ago
International trial shows DNA test could help many breast cancer patients avoid chemotherapy
A new international trial presented at the American Society of Clinical Oncology conference suggests that millions of breast cancer patients
bbc.co.uk·1d ago
Cohort Study Evaluates Age at Onset and Family History as Predictors for Genetic Testing in Parkinson Disease
This cohort study evaluates the association between age at onset (AAO) and family history in Parkinson disease patients who carry pathogenic
doi.org·1d ago